In an analysis of risk prognostic factors for patients with breast cancer [38], researchers found that the expression level of MyD88 in tumor tissues correlated with the stage of cancer differentiation (p = 0.019), and the survival rate of patients with high expression of MyD88 was lower than that of patients with low expression (p = 0.018). This evidence concerns the gene MYD88 and cancer.